OMEPRAZOLE EXTENDED-RELEASE CAPSULES
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F8234 for the delivery of OMEPRAZOLE EXTENDED-RELEASE CAPSULES with NSN 6505013142716. The total contract value is $130.80 and the award was issued on July 24, 2026. This order is being executed under the existing contract SPE2DX25D9900, indicating it is a delivery order placed against a pre-established agreement. The item is procured for federal use as part of the Department of Defense supply chain, with no specified set-aside or NAICS classification. The performance location and point of contact details are not provided, and the primary reference for this award can be accessed via the DIBBS portal using the provided link.
General Info
Agency
Contract Value
$130.8NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
